Literature DB >> 11113096

Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy.

E May1, E Märker-Hermann, B M Wittig, M Zeitz, K H Meyer zum Büschenfelde, R Duchmann.   

Abstract

Intestinal T lymphocytes activated by antigen are suspected to play a key role in enterogenic spondyloarthropathies (SpA). Therefore, we aimed to identify and functionally characterize T-cell clones that are coexpanded in the intestinal mucosa and the synovium. Colon, peripheral blood, and synovium of a patient with enterogenic SpA were screened for clonal T-cell expansions by TCRB-CDR3 length analysis and sequencing. T-cell clones expanded in vivo were isolated from archived synovial cells by targeted T-cell cloning and characterized for phenotype, cytokine production, and antigen specificity. The synovial TCRBV18(+) T-cell repertoire of the patient was dominated by 2 CD8(+) T-cell clones using related CDR3. Both clones were expanded throughout the colon and were present in the peripheral blood. Upon in vitro stimulation with PDB/ionomycin, they showed predominantly interferon gamma and interleukin (IL)-4 but also tumor necrosis factor alpha and IL-10 production and did not specifically lyse autologous T-cell blasts, B-cell lines, or other autologous or allogeneic target or CD1d-transfected cells. These findings strongly suggest that T lymphocytes activated by antigen in the intestinal mucosa contribute to joint inflammation in enterogenic SpA by recognition of antigens specific for the inflamed synovium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113096     DOI: 10.1053/gast.2000.20173

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  CD4+ and CD8+ clonal T cell expansions indicate a role of antigens in ankylosing spondylitis; a study in HLA-B27+ monozygotic twins.

Authors:  R Duchmann; C Lambert; E May; T Höhler; E Märker-Hermann
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

Review 2.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

Review 3.  Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience.

Authors:  J Braun; J Sieper; M Breban; E Collantes-Estevez; J Davis; R Inman; H Marzo-Ortega; H Mielants
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

Review 4.  Occult spondyloarthritis in inflammatory bowel disease.

Authors:  Francesca Bandinelli; Mirko Manetti; Lidia Ibba-Manneschi
Journal:  Clin Rheumatol       Date:  2015-09-10       Impact factor: 2.980

5.  Inflammatory bowel disease associated arthropathy.

Authors:  Sheila L Arvikar; Mark C Fisher
Journal:  Curr Rev Musculoskelet Med       Date:  2011-09

6.  Gastrointestinal issues in children with rheumatologic disease.

Authors:  Mirna Chehade; Keith Benkov
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

Review 7.  Gut inflammation in the spondyloarthropathies.

Authors:  Herman Mielants; Filip De Keyser; Dominique Baeten; Filip Van den Bosch
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

8.  [Update: enterogenic spondylarthritis].

Authors:  Elisabeth Märker-Hermann
Journal:  Z Rheumatol       Date:  2021-05-27       Impact factor: 1.372

Review 9.  The role of the microbiome in rheumatic diseases.

Authors:  Nigel Yeoh; Jeremy P Burton; Praema Suppiah; Gregor Reid; Simon Stebbings
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

10.  HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similar to bacteria-derived peptides.

Authors:  E Frauendorf; H von Goessel; E May; E Märker-Hermann
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.